The ROE as of December 2025 (TTM) for Glenmark Pharmaceuticals Limited (GLENMARK.NS) is 8.72%

According to Glenmark Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current ROE is 8.72%. This represents a change of 291.89% compared to the average of 2.22% of the last 4 quarters.

Glenmark Pharmaceuticals Limited (GLENMARK.NS) Historical ROE (quarterly & annually)

How has GLENMARK.NS ROE performed in the past?

The mean historical ROE of Glenmark Pharmaceuticals Limited over the last ten years is 9.86%. The current 8.72% ROE has changed -11.59% with respect to the historical average. Over the past ten years (40 quarters), GLENMARK.NS's ROE was at its highest in in the December 2016 quarter at 9.74%. The ROE was at its lowest in in the March 2024 quarter at -15.52%.

Glenmark Pharmaceuticals Limited (GLENMARK.NS) ROE by Quarter and Year

Discovering the peaks and valleys of Glenmark Pharmaceuticals Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Glenmark Pharmaceuticals Limited (GLENMARK.NS) Average ROE

How has GLENMARK.NS ROE performed in the past?

The current ROE of Glenmark Pharmaceuticals Limited (GLENMARK.NS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Glenmark Pharmaceuticals Limited (GLENMARK.NS) ROE vs. Peers

How is GLENMARK.NS’s ROE compared to its peers?

Glenmark Pharmaceuticals Limited’s ROE is less than Laurus Labs Limited (15.18%), less than Laurus Labs Limited (15.18%), less than Aurobindo Pharma Limited (10.43%), less than Alkem Laboratories Limited (19.01%), less than Aurobindo Pharma Limited (10.43%), less than Alkem Laboratories Limited (19.01%), less than GlaxoSmithKline Pharmaceuticals Limited (52.46%), less than GlaxoSmithKline Pharmaceuticals Limited (52.46%), less than Biocon Limited (2.02%), less than Biocon Limited (2.02%),

Build a custom stock screener for Glenmark Pharmaceuticals Limited (GLENMARK.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Glenmark Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Glenmark Pharmaceuticals Limited (GLENMARK.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Glenmark Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.